// App-Quantinova.ai

PB1779 : DEVELOPING NOVEL SYNERGISTIC DRUG COMBINATIONS WITH VENETOCLAX IN ACUTE MYELOID LEUKAEMIA

Researchers

Presenter

  • Ruairidh Harrigan

Principal Investigators

  • Evangeline Johnston

  • Kyle Matchett

  • Tony Bjourson

Medical Centers

  • School of Biomedical Sciences,Ulster University,Derry,Соединённое Королевство

  • School of Biomedical Sciences,Ulster University,Derry,Vereinigtes Königreich

  • School of Biomedical Sciences,Ulster University,Derry,Vereinigtes Königreich

  • School of Biomedical Sciences, Ulster University, Coleraine, United Kingdom

  • School of Biomedical Sciences,Ulster University,Derry,Royaume-uni

  • School of Biomedical Sciences,Ulster University,Derry,Royaume-uni

  • School of Biomedical Sciences,Ulster University,Derry,Royaume-uni

  • School of Biomedical Sciences,Ulster University,Derry,Royaume-uni

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • B-cell lymphoma 2

Drug/Treatment

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved